How are STE strangle max profit and max loss calculated?

Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit. For the STE strangle priced from the end-of-day chain at a 30-day expiry (ATM IV 24.60%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$545.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.

What is the breakeven for a STE strangle?

The breakeven for the STE strangle priced on this page is roughly $194.55 and $225.45 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current STE market-implied 1-standard-deviation expected move is approximately 7.05%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.

How does current STE implied volatility affect this strangle?

STE ATM IV is at 24.60% with IV rank near 2.36%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.

STE Strangle Strategy

STE (STERIS plc), in the Healthcare sector, (Medical - Devices industry), listed on NYSE.

STERIS plc provides infection prevention and other procedural products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier and sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors.

STE (STERIS plc) trades in the Healthcare sector, specifically Medical - Devices, with a market capitalization of approximately $20.72B, a trailing P/E of 26.44, a beta of 0.95 versus the broader market, a 52-week range of 195.14-269.44, average daily share volume of 808K, a public-listing history dating back to 1992, approximately 18K full-time employees. These structural characteristics shape how STE stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 0.95 places STE roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline. STE pays a dividend, which adjusts put-call parity and shifts the ex-dividend pricing across the listed chain.

What is a strangle on STE?

A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money.

Current STE snapshot

As of May 15, 2026, spot at $211.98, ATM IV 24.60%, IV rank 2.36%, expected move 7.05%. The strangle on STE below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.

Why this strangle structure on STE specifically: STE IV at 24.60% is on the cheap side of its 1-year range, which favors premium-buying structures like a STE strangle, with a market-implied 1-standard-deviation move of approximately 7.05% (roughly $14.95 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated STE expiries trade a higher absolute premium for lower per-day decay. Position sizing on STE should anchor to the underlying notional of $211.98 per share and to the trader's directional view on STE stock.

STE strangle setup

The STE strangle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With STE near $211.98, the first option leg uses a $220.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed STE chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 STE shares for the stock leg in covered calls and collars).

Action	Type	Strike / Basis	Premium (est)
Buy 1	Call	$220.00	$3.40
Buy 1	Put	$200.00	$2.05

STE strangle risk and reward

Net Premium / Debit: -$545.00
Max Profit (per contract): Unbounded
Max Loss (per contract): -$545.00
Breakeven(s): $194.55, $225.45
Risk / Reward Ratio: Unbounded

Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit.

STE strangle payoff curve

Modeled P&L at expiration across a range of underlying prices for the strangle on STE. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

Underlying Price	% From Spot	P&L at Expiration
$0.01	-100.0%	+$19,454.00
$46.88	-77.9%	+$14,767.12
$93.75	-55.8%	+$10,080.23
$140.62	-33.7%	+$5,393.35
$187.49	-11.6%	+$706.46
$234.35	+10.6%	+$890.42
$281.22	+32.7%	+$5,577.31
$328.09	+54.8%	+$10,264.19
$374.96	+76.9%	+$14,951.08
$421.83	+99.0%	+$19,637.96

When traders use strangle on STE

Strangles on STE are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the STE chain.

STE thesis for this strangle

The market-implied 1-standard-deviation range for STE extends from approximately $197.03 on the downside to $226.93 on the upside. A STE long strangle is the OTM cousin of the straddle: lower up-front cost but the underlying has to travel further past either OTM strike before the position turns profitable at expiration. Current STE IV rank near 2.36% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on STE at 24.60%. As a Healthcare name, STE options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to STE-specific events.

STE strangle positions are structurally neutral / high-volatility (long premium, OTM); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. STE positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move STE alongside the broader basket even when STE-specific fundamentals are unchanged. Always rebuild the position from current STE chain quotes before placing a trade.

Frequently asked questions

What is a strangle on STE?: A strangle on STE is the strangle strategy applied to STE (stock). The strategy is structurally neutral / high-volatility (long premium, OTM): A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money. With STE stock trading near $211.98, the strikes shown on this page are snapped to the nearest listed STE chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are STE strangle max profit and max loss calculated?: Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit. For the STE strangle priced from the end-of-day chain at a 30-day expiry (ATM IV 24.60%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$545.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a STE strangle?: The breakeven for the STE strangle priced on this page is roughly $194.55 and $225.45 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current STE market-implied 1-standard-deviation expected move is approximately 7.05%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a strangle on STE?: Strangles on STE are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the STE chain.
How does current STE implied volatility affect this strangle?: STE ATM IV is at 24.60% with IV rank near 2.36%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.